The Relationship between Delirium and Statin Use According to Disease Severity in Patients in the Intensive Care Unit
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Objective: The aim of this study was to investigate the association between the use of statins and the occurrence of delirium in a large cohort of patients in the intensive care unit (ICU), considering disease severity and statin properties. Methods: We obtained clinical and demographical information from 3,604 patients admitted to the ICU from January 2013 to April 2020. This included information on daily statin use and delirium state, as assessed by the Confusion Assessment Method for ICU. We used inverse probability of treatment weighting and categorized the patients into four groups based on the Acute Physiology and Chronic Health Evaluation II score (group 1: 0−10 - mild; group 2: 11−20 - mild to moderate; group 3: 21−30 - moderate to severe; group 4: > 30 - severe). We analyzed the association between the use of statin and the occurrence of delirium in each group, while taking into account the properties of statins. Results: Comparisons between statin and non-statin patient groups revealed that only in group 2, patients who were administered statin showed significantly higher occurrence of delirium (p = 0.004, odds ratio [OR] = 1.58) compared to the patients who did not receive statin. Regardless of whether statins were lipophilic (p = 0.036, OR = 1.47) or hydrophilic (p = 0.032, OR = 1.84), the occurrence of delirium was higher only in patients from group 2. Conclusion: The use of statins may be associated with the increases in the risk of delirium occurrence in patients with mild to moderate disease severity, irrespective of statin properties.
Abstract
Objective: The aim of this study was to investigate the association between the use of statins and the occurrence of delirium in a large cohort of patients in the intensive care unit (ICU), considering disease severity and statin properties. Methods: We obtained clinical and demographical information from 3,604 patients admitted to the ICU from January 2013 to April 2020. This included information on daily statin use and delirium state, as assessed by the Confusion Assessment Method for ICU. We used inverse probability of treatment weighting and categorized the patients into four groups based on the Acute Physiology and Chronic Health Evaluation II score (group 1: 0−10 - mild; group 2: 11−20 - mild to moderate; group 3: 21−30 - moderate to severe; group 4: > 30 - severe). We analyzed the association between the use of statin and the occurrence of delirium in each group, while taking into account the properties of statins. Results: Comparisons between statin and non-statin patient groups revealed that only in group 2, patients who were administered statin showed significantly higher occurrence of delirium (p = 0.004, odds ratio [OR] = 1.58) compared to the patients who did not receive statin. Regardless of whether statins were lipophilic (p = 0.036, OR = 1.47) or hydrophilic (p = 0.032, OR = 1.84), the occurrence of delirium was higher only in patients from group 2. Conclusion: The use of statins may be associated with the increases in the risk of delirium occurrence in patients with mild to moderate disease severity, irrespective of statin properties.
참고문헌 (49)
- Francis J, "Delirium in older patients", J Am Geriatr Soc, 40, pp.829~838 (1992)
- Levkoff SE, "Delirium. The occurrence and persistence of symptoms among elderly hospitalized patients", Arch Intern Med, 152, pp.334~340 (1992)
- Pandharipande PP, "Long-term cognitive impairment after critical illness", N Engl J Med, 370, pp.185~186 (2014)
- Witlox J, "Delirium in elderly patients and the risk of postdischarge mortality, institutionalization, and dementia : a meta-analysis", JAMA, 304, pp.443~451 (2010)
- Oh ES, "Antipsychotics for preventing delirium in hospitalized adults : a systematic review", Ann Intern Med, 171, pp.474~484 (2019)
- Hudetz JA, "Ketamine attenuates delirium after cardiac surgery with cardiopulmonary bypass", J Cardiothorac Vasc Anesth, 23, pp.651~657 (2009)
- Liptzin B, "Donepezil in the prevention and treatment of post-surgical delirium", Am J Geriatr Psychiatry, 13, pp.1100~1106 (2005)
- Inouye SK, "A multicomponent intervention to prevent delirium in hospitalized older patients", N Engl J Med, 340, pp.669~676 (1999)
- Marcantonio ER, "Reducing delirium after hip fracture : a randomized trial", J Am Geriatr Soc, 49, pp.516~522 (2001)
- Inouye SK, "Delirium in elderly people", Lancet, 383, pp.911~922 (2014)
- Maldonado JR, "Neuropathogenesis of delirium : review of current etiologic theories and common pathways", Am J Geriatr Psychiatry, 21, pp.1190~1222 (2013)
- Semmler A, "Systemic inflammation induces apoptosis with variable vulnerability of different brain regions", J Chem Neuroanat, 30, pp.144~157 (2005)
- Cerejeira J, "The neuroinflammatory hypothesis of delirium", Acta Neuropathol, 119, pp.737~754 (2010)
- Stone NJ, "2013 ACC", AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults : a report of the American College of Cardiology, J Am Coll Cardiol, pp.2014, 63(25 Pt B)[DOI]
- Antonopoulos AS, "Statins as anti-inflammatory agents in atherogenesis : molecular mechanisms and lessons from the recent clinical trials", Curr Pharm Des, 18, pp.1519~1530 (2012)
- Schönbeck U, "Inflammation, immunity, and HMG-CoA reductase inhibitors: statins as antiinflammatory agents?", Circulation, 109(21 Suppl 1), pp.II18~II26 (2004)
- Terblanche M, "Statins and sepsis : multiple modifications at multiple levels", Lancet Infect Dis, 7, pp.358~368 (2007)
- Morandi A, "Statins and brain dysfunction : a hypothesis to reduce the burden of cognitive impairment in patients who are critically ill", Chest, 140, pp.580~585 (2011)
- Wang H, "Simvastatin and atorvastatin improve behavioral outcome, reduce hippocampal degeneration, and improve cerebral blood flow after experimental traumatic brain injury", Exp Neurol, 206, pp.59~69 (2007)
- Vallabhajosyula S, "Role of statins in delirium prevention in critical ill and cardiac surgery patients : a systematic review and meta-analysis", J Crit Care, 37, pp.189~196 (2017)
- Mather JF, "Statin and its association with delirium in the medical ICU", Crit Care Med, 45, pp.1515~1522 (2017)
- Morandi A, "Statins and delirium during critical illness : a multicenter, prospective cohort study", Crit Care Med, 42, pp.1899~1909 (2014)
- Page VJ, "Statin use and risk of delirium in the critically ill", Am J Respir Crit Care Med, 189, pp.666~673 (2014)
- Redelmeier DA, "Delirium after elective surgery among elderly patients taking statins", CMAJ, 179, pp.645~652 (2008)
- Wood WG, "Statins and neuroprotection : a prescription to move the field forward", Ann N Y Acad Sci, 1199, pp.69~76 (2010)
- Schultz BG, "The role of statins in both cognitive impairment and protection against dementia : a tale of two mechanisms", Transl Neurodegener, 7, pp.5~ (2018)
- Ahmed S, "Risk factors for incident delirium among older people in acute hospital medical units : a systematic review and meta-analysis", Age Ageing, 43, pp.326~333 (2014)
- Young J, "Diagnosis, prevention, and management of delirium : summary of NICE guidance", BMJ, 341, pp.c3704~ (2010)
- Almog Y, "Prior statin therapy is associated with a decreased rate of severe sepsis", Circulation, 110, pp.880~885 (2004)
- Oh J, "Mutual relationship between anxiety and pain in the intensive care unit and its effect on medications", J Crit Care, 30, pp.1043~1048 (2015)
- Ely EW, "Delirium in mechanically ventilated patients : validity and reliability of the confusion assessment method for the intensive care unit(CAM-ICU)", JAMA, 286, pp.2703~2710 (2001)
- Sessler CN, "The Richmond Agitation-Sedation Scale : validity and reliability in adult intensive care unit patients", Am J Respir Crit Care Med, 166, pp.1338~1344 (2002)
- Meagher D, "A new data-based motor subtype schema for delirium", J Neuropsychiatry Clin Neurosci, 20, pp.185~193 (2008)
- Knaus WA, "APACHE II : a severity of disease classification system", Crit Care Med, 13, pp.818~829 (1985)
- Bouch DC, "Severity scoring systems in the critically ill", Contin Educ Anaesth Crit Care Pain, 8, pp.181~185 (2008)
- Rosenbaum PR, "Model-based direct adjustment", J Am Stat Assoc, 82, pp.387~394 (1987)
- Lunceford JK, "Stratification and weighting via the propensity score in estimation of causal treatment effects : a comparative study", Stat Med, 23, pp.2937~2960 (2004)
- Austin PC, "Moving towards best practice when using inverse probability of treatment weighting(IPTW)using the propensity score to estimate causal treatment effects in observational studies", Stat Med, 34, pp.3661~3679 (2015)
- Oldroyd C, "A systematic review and meta-analysis of factors for delirium in vascular surgical patients", J Vasc Surg, 66, pp.1269~1279 (2017)
- Sugimoto M, "Pre-and intraoperative predictors of delirium after open abdominal aortic aneurysm repair", Ann Vasc Dis, 8, pp.215~219 (2015)
- Katznelson R, "Delirium following vascular surgery : increased incidence with preoperative beta-blocker administration", Can J Anaesth, 56, pp.793~801 (2009)
- Kirkebøen KA, "The role of nitric oxide in sepsis--an overview", Acta Anaesthesiol Scand, 43, pp.275~288 (1999)
- Titheradge MA, "Nitric oxide in septic shock", Biochim Biophys Acta, 1411, pp.437~455 (1999)
- Ting-I Chiang, "Novel Biomarkers of Alzheimer’s Disease: Based Upon N-methyl-D-aspartate Receptor Hypoactivation and Oxidative Stress", Clinical Psychopharmacology and Neuroscience, 19(3), pp.423~433 (2021), 대한정신약물학회[DOI]
- McGown CC, "Beneficial effects of statins on the microcirculation during sepsis : the role of nitric oxide", Br J Anaesth, 98, pp.163~175 (2007)
- White RP, "Effect of inhibition of nitric oxide synthase on dynamic cerebral autoregulation in humans", Clin Sci(Lond), 99, pp.555~560 (2000)
- Tanaka K, "Inhibition of nitric oxide synthesis impairs autoregulation of local cerebral blood flow in the rat", Neuroreport, 4, pp.267~270 (1993)
- Marcantonio ER, "Statins and postoperative delirium", CMAJ, 179, pp.627~628 (2008)
- Jegan Yogaratnam, "Prolonged Delirium Secondary to Hypoxic-ischemic Encephalopathy Following Cardiac Arrest", Clinical Psychopharmacology and Neuroscience, 11(1), pp.39~42 (2013), 대한정신약물학회
